Shanghai, China

Jingtao Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jingtao Wang. Retrieved from https://idiyas.com/inventor/jingtao-wang-18kpqnec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jingtao Wang: Innovator in Fatty Acid Compounds

Introduction

Jingtao Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of fatty acid compounds, particularly in their preparation methods and applications. His work is crucial in addressing health issues such as obesity and diabetes.

Latest Patents

Jingtao Wang holds a patent for a fatty acid compound, which includes a preparation method and its uses. The invention relates to a class of fatty acid compounds that possess the ability to activate APMK and inhibit glucose output in mouse primary hepatocytes. This innovative compound can be utilized in the development of medicaments aimed at treating obesity or diabetes. He has 1 patent to his name.

Career Highlights

Wang is affiliated with the Chinese Academy of Sciences, where he conducts his research and development. His work has garnered attention for its potential impact on public health, particularly in the management of metabolic disorders.

Collaborations

Some of his notable coworkers include Fajun Nan and Jia Tao Li, who contribute to the collaborative efforts in research and innovation within the academy.

Conclusion

Jingtao Wang's contributions to the field of fatty acid compounds highlight his role as an innovator in medical research. His work not only advances scientific knowledge but also offers potential solutions for pressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…